Industry Developments

BMI View: DHL's willingness to invest in cold-chain storage facilities and distribution networks suggests Latin America's drugmakers are not only interested in improving quality standards,... 2011-09-27

BMI View: While tightening market conditions are likely to continue to hurt medicine sales across Europe, we commend Spanish drugmaker Faes Farma's decision to pursue growth opportunities... 2011-09-27

BMI View: Although an emphasis on preventative care and personal responsibility are likely to curb the small territory's escalating healthcare costs, BMI believes the Cayman Islands'... 2011-09-26

BMI View: Healthcare spending in the US will continue to account for a disproportionately large percentage of its GDP. Citizens of the world's largest economy are accustomed to regular... 2011-09-23

BMI View: We see Teuto's decision to focus on advanced drug manufacturing systems, along with its product portfolio of innovative and generic medicines, as a further improvement in... 2011-09-23

BMI View: Despite our generally positive outlook on Mexico's push towards universal access to healthcare, recent developments have suggested that weak and short-sighted procurement... 2011-09-22

BMI view: While there is clear demand for Orexigen's obesity drug Contrave in the US, we believe shareholders may still have to wait a long time to see a return on investment. Despite... 2011-09-22

BMI View: While BMI does not expect Chile's government to drastically raise financial penalties or introduce new regulations, we believe the media frenzy and apparent public outrage... 2011-09-21

BMI View: While we believe Brazil's intellectual property laws do little to help the country's otherwise positive business environment, we are impressed by the government's push... 2011-09-20

BMI View: While Aspen Pharmaceuticals has shifted its focus away from its domestic market, we believe the company's continuing success depends on increasing expansion efforts in countries... 2011-09-16